- Home
- LUCD vs NKTR Comparison
LUCD vs NKTR Comparison
Compare LUCD & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LUCD
- NKTR
- Stock Information
- Founded
- LUCD 2018
- NKTR 1990
- Country
- LUCD United States
- NKTR United States
- Employees
- LUCD N/A
- NKTR N/A
- Industry
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- LUCD Health Care
- NKTR Health Care
- Exchange
- LUCD Nasdaq
- NKTR Nasdaq
- Market Cap
- LUCD 140.7M
- NKTR 125.5M
- IPO Year
- LUCD 2021
- NKTR 1994
- Fundamental
- Price
- LUCD $1.26
- NKTR $8.51
- Analyst Decision
- LUCD Strong Buy
- NKTR Strong Buy
- Analyst Count
- LUCD 4
- NKTR 6
- Target Price
- LUCD $3.94
- NKTR $73.75
- AVG Volume (30 Days)
- LUCD 1.2M
- NKTR 348.5K
- Earning Date
- LUCD 08-11-2025
- NKTR 08-07-2025
- Dividend Yield
- LUCD N/A
- NKTR N/A
- EPS Growth
- LUCD N/A
- NKTR N/A
- EPS
- LUCD N/A
- NKTR N/A
- Revenue
- LUCD $4,173,000.00
- NKTR $87,248,000.00
- Revenue This Year
- LUCD $91.46
- NKTR N/A
- Revenue Next Year
- LUCD $213.42
- NKTR N/A
- P/E Ratio
- LUCD N/A
- NKTR N/A
- Revenue Growth
- LUCD 39.89
- NKTR N/A
- 52 Week Low
- LUCD $0.68
- NKTR $6.48
- 52 Week High
- LUCD $1.80
- NKTR $22.79
- Technical
- Relative Strength Index (RSI)
- LUCD 46.57
- NKTR 42.19
- Support Level
- LUCD $1.21
- NKTR $7.99
- Resistance Level
- LUCD $1.34
- NKTR $9.71
- Average True Range (ATR)
- LUCD 0.08
- NKTR 1.37
- MACD
- LUCD -0.01
- NKTR -0.20
- Stochastic Oscillator
- LUCD 50.00
- NKTR 11.66
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.